SB-568859

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-568859, covering 2012-06-04 to 2012-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Of Two Tablet Formulations Of SB-568859 [Phase 1]